# EKF Diagnostics
---
Who / What
EKF Diagnostics is a publicly listed healthcare company specializing in the development, construction, and manufacturing of point-of-care diagnostic devices. Its products include analyzers for hemoglobin (Hb), HbA1c, glucose, lactate, clinical chemistry tests, and biomarker-based ELISA & rapid tests.
---
Background & History
Founded in **1990** in Barleben, Germany, EKF Diagnostics initially operated as a local manufacturer before expanding globally. By the early 2000s, it relocated its headquarters to Cardiff, Wales, UK, consolidating operations across Europe and beyond. The company’s growth accelerated with strategic acquisitions, including **Stanbio Laboratory Products** (specializing in ELISA tests) and **Argutus Medical** (clinical chemistry solutions). As of December 31, 2011, it operated nine facilities in six countries, employing approximately **295 people**.
---
Why Notable
EKF Diagnostics plays a pivotal role in the medical diagnostics sector by providing rapid, accurate, and portable testing solutions for clinicians. Its innovations—such as point-of-care analyzers and biomarker-based tests—enhance patient care by enabling faster decision-making in healthcare settings. The company’s acquisitions have strengthened its market position in clinical chemistry and glucose monitoring, positioning it as a key player in global diagnostics.
---
In the News
While specific recent news coverage isn’t detailed in available sources, EKF Diagnostics remains relevant due to its continued expansion in Europe and emerging markets. Its focus on point-of-care diagnostics aligns with growing demand for efficient, patient-centric healthcare solutions, particularly in areas like diabetes management and infectious disease screening.
---
Key Facts
---
